---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-25-001693"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:06:11.575607+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeloc Technologies Reports Q3 2025 Revenue Up 8% but Net Loss Widens to $263K

## Summary
- Q3 2025 net revenue $2.257M, up 8% from $2.087M in Q3 2024, but net loss increased to $(263K) from $(158K).
- Gross margin declined to 40.2% from 43.7% due to cost inflation and tariffs.
- SpinDetect centrifugal drug analyzer beta testing for THC detection underway; commercial launch expected in 2026.
- Nine-month 2025 net loss $(950K) vs $(740K) same period 2024, revenue $6.754M vs $6.628M.
- Shares began trading on OTCID July 1, 2025, replacing OTC Pink.

## SEC filing metadata
- accession: 0001079973-25-001693
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997325001693/0001079973-25-001693-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997325001693/lctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-25-001693
- JSON: https://secwatch.observer/filing/0001079973-25-001693.json
- Plain text: https://secwatch.observer/filing/0001079973-25-001693.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.